Leone Patterson

Leone Patterson's Title

Leone Patterson currently holds the position of Chief Financial and Business Officer at Tenaya Therapeutics, a role she has been in since June 2021. In this critical position, Patterson oversees the company’s financial strategy and business operations, leveraging her extensive experience to drive financial performance and strategic growth.

Leone Patterson's Company

Tenaya Therapeutics is a biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying causes of heart disease. Since joining Tenaya Therapeutics, Leone Patterson has played a vital role in steering the company’s financial strategies and business operations, ensuring robust financial health and facilitating pioneering research and development efforts.

Leone Patterson's Background

Leone Patterson has a rich background in finance and executive leadership within the biopharmaceutical industry. She has served in various high-level roles, including President and Chief Financial Officer at Adverum Biotechnologies, and as CEO and Director of the same company. Her career also encompasses significant positions such as Chief Financial Officer at Diadexus and Transcept, as well as senior finance roles at Exelixis, Novartis, and Chiron. Earlier in her career, she honed her auditing skills at the accounting firm KPMG.

Leone Patterson's Education and Expertise

Leone Patterson is well-versed in both business administration and accounting, holding a B.S. from Chapman University. She further advanced her executive skills by earning an executive MBA from St. Mary’s College. Additionally, Patterson is a Certified Public Accountant (inactive status), which underscores her expertise in financial management and auditing. Her educational background and certifications provide a solid foundation for her strategic roles in the biopharmaceutical sector.

Leone Patterson's Achievements

Leone Patterson has achieved significant milestones throughout her career, including leadership roles that have shaped the financial and operational strategies of prominent biopharmaceutical companies. Notably, she has served on the Board of Directors of Nkarta, Inc. and Oxford Biomedica, both of which are pivotal companies in the biopharmaceutical industry. Her contributions have been instrumental in driving innovation and growth within these organizations, showcasing her adeptness in governance and strategic oversight.